Clinical trial
Risk-stratified Osteoporosis Strategy Evaluation Study (ROSE)
NCT01388244 is registered in ClinicalTrials.gov with Odense University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Risk-stratified Osteoporosis Strategy Evaluation Study (ROSE)
- Lead sponsor
- Odense University Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 28, 2010
- Completion date
- December 31, 2021
- Enrollment
- 35,000 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.